{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:41:54Z","timestamp":1786372914355,"version":"build-2736575974"},"reference-count":71,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Supplement_1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.2215\/cjn.05880809","type":"journal-article","created":{"date-parts":[[2010,1,13]],"date-time":"2010-01-13T15:26:25Z","timestamp":1263396385000},"page":"S31-S40","source":"Crossref","is-referenced-by-count":33,"title":["Ten-Year Experience with Sevelamer and Calcium Salts as Phosphate Binders"],"prefix":"10.2215","volume":"5","author":[{"given":"Paolo","family":"Raggi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slobodan","family":"Vukicevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Maria","family":"Moys\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Wesseling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Spiegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20230601","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2004070602","article-title":"Serum phosphate levels and mortality risk among people with chronic kidney disease","volume":"16","author":"Kestenbaum","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R2-5-20230601","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1681\/ASN.2007080854","article-title":"Mechanisms of vascular calcification in chronic kidney disease","volume":"19","author":"Moe","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R3-5-20230601","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/ki.2009.246","article-title":"A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease","volume":"76","author":"Isakova","year":"2009","journal-title":"Kidney Int"},{"key":"R4-5-20230601","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","article-title":"Treat to Goal Working Group: Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients","volume":"62","author":"Chertow","year":"2002","journal-title":"Kidney Int"},{"key":"R5-5-20230601","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1053\/j.ajkd.2008.02.298","article-title":"A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: The Calcium Acetate Renagel Evaluation-2 (CARE-2) study","volume":"51","author":"Qunibi","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"R6-5-20230601","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/j.1523-1755.2005.00600.x","article-title":"Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis","volume":"68","author":"Block","year":"2005","journal-title":"Kidney Int"},{"key":"R7-5-20230601","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/sj.ki.5002466","article-title":"Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients","volume":"72","author":"Suki","year":"2007","journal-title":"Kidney Int"},{"key":"R8-5-20230601","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1097\/01.ASN.0000141960.01035.28","article-title":"Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: A potential mechanism for accelerated vascular calcification in ESRD","volume":"15","author":"Reynolds","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R9-5-20230601","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1111\/j.1523-1755.2004.66015.x","article-title":"Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro","volume":"66","author":"Yang","year":"2004","journal-title":"Kidney Int"},{"key":"R10-5-20230601","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ahj.2004.07.023","article-title":"Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients","volume":"149","author":"Ferramosca","year":"2005","journal-title":"Am Heart J"},{"key":"R11-5-20230601","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000111061","article-title":"Effects of sevelamer and calcium-based phosphate binders on lipid and inflammatory markers in hemodialysis patients","volume":"28","author":"Shantouf","year":"2008","journal-title":"Am J Nephrol"},{"key":"R12-5-20230601","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/art.20781","article-title":"Effects of sevelamer and calcium-based phosphate binders on uric acid concentrations in patients undergoing hemodialysis: A randomized clinical trial","volume":"52","author":"Garg","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R13-5-20230601","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1359\/JBMR.041221","article-title":"Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis","volume":"20","author":"Raggi","year":"2005","journal-title":"J Bone Miner Res"},{"key":"R14-5-20230601","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1681\/ASN.2006101089","article-title":"Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients","volume":"19","author":"Ferreira","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R15-5-20230601","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1681\/ASN.2006050490","article-title":"Reversal of the adynamic bone disorder and decreased vascular calcification in chronic kidney disease by sevelamer carbonate therapy","volume":"18","author":"Mathew","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R16-5-20230601","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1093\/ndt\/gfh894","article-title":"Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density","volume":"20","author":"Asmus","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R17-5-20230601","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO): Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"key":"R18-5-20230601","first-page":"381","article-title":"Simultaneous lowering of serum phosphate and LDL-cholesterol by sevelamer hydrochloride (RenaGel) in dialysis patients","volume":"50","author":"Wilkes","year":"1998","journal-title":"Clin Nephrol"},{"key":"R19-5-20230601","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1523-1755.1999.00273.x","article-title":"Inflammation enhances cardiovascular risk and mortality in hemodialysis patients","volume":"55","author":"Zimmermann","year":"1999","journal-title":"Kidney Int"},{"key":"R20-5-20230601","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/ndt\/17.suppl_8.29","article-title":"C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients","volume":"17","author":"Wanner","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"R21-5-20230601","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R22-5-20230601","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/sj.ki.5002518","article-title":"The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer","volume":"72","author":"Russo","year":"2007","journal-title":"Kidney Int"},{"key":"R23-5-20230601","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1159\/000095782","article-title":"Serum fetuin-A levels link inflammation and cardiovascular calcification in hemodialysis patients","volume":"26","author":"Cozzolino","year":"2006","journal-title":"Am J Nephrol"},{"key":"R24-5-20230601","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(03)12710-9","article-title":"Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: A cross-sectional study","volume":"361","author":"Ketteler","year":"2003","journal-title":"Lancet"},{"key":"R25-5-20230601","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1111\/j.1523-1755.2005.00345.x","article-title":"Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin","volume":"67","author":"Stenvinkel","year":"2005","journal-title":"Kidney Int"},{"key":"R26-5-20230601","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/sj.ki.5002178","article-title":"Association of serum fetuin-A levels with mortality in dialysis patients","volume":"72","author":"Hermans","year":"2007","journal-title":"Kidney Int"},{"key":"R27-5-20230601","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/sj.ki.5002549","article-title":"Fetuin-A is not associated with mortality in chronic kidney disease","volume":"72","author":"Ix","year":"2007","journal-title":"Kidney Int"},{"key":"R28-5-20230601","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2215\/CJN.02810707","article-title":"Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients","volume":"3","author":"Caglar","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R29-5-20230601","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5001514","article-title":"Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients","volume":"70","author":"Kalantar-Zadeh","year":"2006","journal-title":"Kidney Int"},{"key":"R30-5-20230601","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000100044","article-title":"Progression of coronary artery calcification in predialysis patients","volume":"27","author":"Russo","year":"2007","journal-title":"Am J Nephrol"},{"key":"R31-5-20230601","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/ndt\/18.3.582","article-title":"Sevelamer hydrochloride with or without alphacalcidol or higher dialysate calcium vs calcium carbonate in dialysis patients: An open-label, randomized study","volume":"18","author":"Sadek","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"R32-5-20230601","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1681\/ASN.2006080936","article-title":"Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: The Mild to Moderate Kidney Disease (MMKD) Study","volume":"18","author":"Fliser","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R34-5-20230601","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N Engl J Med"},{"key":"R35-5-20230601","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1744-9987.2005.00293.x","article-title":"Sevelamer hydrochloride and calcium bicarbonate reduce serum fibroblast growth factor 23 levels in dialysis patients","volume":"9","author":"Koiwa","year":"2005","journal-title":"Ther Apher Dial"},{"key":"R36-5-20230601","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1159\/000135692","article-title":"Precision of biomarkers to define chronic inflammation in CKD","volume":"28","author":"LaClair","year":"2008","journal-title":"Am J Nephrol"},{"key":"R37-5-20230601","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1161\/hy1001.096358","article-title":"Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease","volume":"38","author":"Blacher","year":"2001","journal-title":"Hypertension"},{"key":"R38-5-20230601","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/ndt\/gfn466","article-title":"Vascular calcifications, vertebral fractures and mortality in haemodialysis patients","volume":"24","author":"Rodriguez-Garcia","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R39-5-20230601","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1053\/j.ajkd.2004.07.022","article-title":"Coronary artery calcification in patients with CRF not undergoing dialysis","volume":"44","author":"Russo","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"R40-5-20230601","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/sj.ki.5002059","article-title":"Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients","volume":"71","author":"Block","year":"2007","journal-title":"Kidney Int"},{"key":"R41-5-20230601","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"key":"R42-5-20230601","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/ndt\/15.7.1014","article-title":"Arterial stiffening and vascular calcifications in end-stage renal disease","volume":"15","author":"Guerin","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"R43-5-20230601","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1681\/ASN.2008040349","article-title":"Association of serum phosphate with vascular and valvular calcification in moderate CKD","volume":"20","author":"Adeney","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R44-5-20230601","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1681\/ASN.2008060609","article-title":"Phosphorus binders and survival on hemodialysis","volume":"20","author":"Isakova","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R45-5-20230601","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","article-title":"Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality","volume":"18","author":"London","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"R46-5-20230601","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1681\/ASN.2004110932","article-title":"Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation","volume":"16","author":"Litwin","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R47-5-20230601","doi-asserted-by":"crossref","first-page":"104","DOI":"10.5414\/CNP62104","article-title":"Long-term comparison of a calcium-free phosphate binder and calcium carbonate\u2013phosphorus metabolism and cardiovascular calcification","volume":"62","author":"Braun","year":"2004","journal-title":"Clin Nephrol"},{"key":"R48-5-20230601","doi-asserted-by":"crossref","first-page":"c273","DOI":"10.1159\/000170783","article-title":"Phosphate binder impact on bone remodeling and coronary calcification: Results from the BRiC study","volume":"110","author":"Barreto","year":"2008","journal-title":"Nephron Clin Pract"},{"key":"R49-5-20230601","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/jarr.2003.50016","article-title":"Meta-analysis of the effect of sevelamer on phosphorus, calcium, PTH, and serum lipids in dialysis patients","volume":"10","author":"Burke","year":"2003","journal-title":"Adv Ren Replace Ther"},{"key":"R51-5-20230601","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/ki.2008.407","article-title":"Cinacalcet suppresses calcification of the aorta and heart in uremic rats","volume":"74","author":"Kawata","year":"2008","journal-title":"Kidney Int"},{"key":"R52-5-20230601","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1681\/ASN.2005040342","article-title":"Calcimimetic R-568 decreases extraosseous calcifications in uremic rats treated with calcitriol","volume":"17","author":"Lopez","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R53-5-20230601","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1093\/ndt\/gfp078","article-title":"R-568 reduces ectopic calcification in a rat model of chronic kidney disease-mineral bone disorder (CKD-MBD)","volume":"24","author":"Moe","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R54-5-20230601","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.bone.2009.03.653","article-title":"Effects of calcimimetic on vascular calcification and atherosclerosis in uremic mice","volume":"45","author":"Joki","year":"2009","journal-title":"Bone"},{"key":"R55-5-20230601","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/j.ajkd.2005.04.035","article-title":"Changes in cardiovascular calcification after parathyroidectomy in patients with ESRD","volume":"46","author":"Bleyer","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"R56-5-20230601","article-title":"Successful near-total parathyroidectomy inhibits long-term coronary calcification progression in patients undergoing hemodialysis, SA\u2013PO2719","volume":"19","author":"Sharma","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R57-5-20230601","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1093\/ndt\/gfn393","article-title":"Calcium-containing phosphate binders in dialysis patients with cardiovascular calcifications: Should we CARE-2 avoid them?","volume":"23","author":"Floege","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R58-5-20230601","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1161\/CIRCULATIONAHA.104.512681","article-title":"Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES)","volume":"112","author":"Raggi","year":"2005","journal-title":"Circulation"},{"key":"R59-5-20230601","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1161\/CIRCULATIONAHA.105.568147","article-title":"Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: A multicenter, randomized, double-blind trial","volume":"113","author":"Schmermund","year":"2006","journal-title":"Circulation"},{"key":"R60-5-20230601","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jacc.2005.02.089","article-title":"Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: The St. Francis Heart Study randomized clinical trial","volume":"46","author":"Arad","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R61-5-20230601","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00467-007-0671-3","article-title":"Chronic kidney disease mineral and bone disorder in children","volume":"23","author":"Wesseling","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"R62-5-20230601","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1523-1755.2003.00126.x","article-title":"Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats","volume":"64","author":"Katsumata","year":"2003","journal-title":"Kidney Int"},{"key":"R63-5-20230601","first-page":"284","article-title":"Improvements in renal osteodystrophy in patients treated with lanthanum carbonate for two years","volume":"70","author":"Malluche","year":"2008","journal-title":"Clin Nephrol"},{"key":"R64-5-20230601","first-page":"428","article-title":"The effects of lanthanum carbonate and calcium carbonate on bone abnormalities in patients with end-stage renal disease","volume":"64","author":"Freemont","year":"2005","journal-title":"Clin Nephrol"},{"key":"R65-5-20230601","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1681\/ASN.2004100885","article-title":"Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols","volume":"16","author":"Salusky","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R67-5-20230601","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00223-005-0294-2","article-title":"Effects of lanthanum on composition, crystal size, and lattice structure of femur bone mineral of Wistar rats","volume":"78","author":"Huang","year":"2006","journal-title":"Calcif Tissue Int"},{"key":"R68-5-20230601","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1097\/01.ASN.0000133022.32912.95","article-title":"Does the phosphate binder lanthanum carbonate affect bone in rats with chronic renal failure?","volume":"15","author":"Behets","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R69-5-20230601","doi-asserted-by":"crossref","first-page":"138","DOI":"10.5414\/CNP63138","article-title":"Utilization of bone histomorphometry in renal osteodystrophy: Demonstration of a new approach using data from a prospective study of lanthanum carbonate","volume":"63","author":"Freemont","year":"2005","journal-title":"Clin Nephrol"},{"key":"R70-5-20230601","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.1210\/en.2008-0205","article-title":"Sevelamer restores bone volume and improves bone microarchitecture and strength in aged ovariectomized rats","volume":"149","author":"Sampath","year":"2008","journal-title":"Endocrinology"},{"key":"R71-5-20230601","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1365-2710.2007.00871.x","article-title":"Survival in end stage renal disease: Calcium carbonate vs. sevelamer","volume":"32","author":"Borzecki","year":"2007","journal-title":"J Clin Pharm Ther"},{"key":"R72-5-20230601","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1053\/j.ajkd.2007.12.002","article-title":"A comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and morbidity in hemodialysis: A secondary analysis of the Dialysis Clinical Outcomes Revisited (DCOR) randomized trial using claims data","volume":"51","author":"St Peter","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"R74-5-20230601","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1681\/ASN.2005101085","article-title":"Chronic kidney disease and mortality risk: A systematic review","volume":"17","author":"Tonelli","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R75-5-20230601","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1053\/j.ajkd.2009.06.004","article-title":"Benefits and harms of phosphate binders in CKD: A systematic review of randomized controlled trials","volume":"54","author":"Navaneethan","year":"2009","journal-title":"Am J Kidney Dis"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201001001-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:39:21Z","timestamp":1786369161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201001001-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":71,"journal-issue":{"issue":"Supplement_1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.05880809","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}